Literature DB >> 24377013

Underestimation of cancer in case of diagnosis of atypical ductal hyperplasia (ADH) by vacuum assisted core needle biopsy.

Karol Polom1, Dawid Murawa1, Paweł Kurzawa2, Michał Michalak3, Paweł Murawa1.   

Abstract

BACKGROUND: With the introduction of mammography screening, we are more often dealing with the diagnosis of precancerous and preinvasive breast lesions. An increasing number of patients are observed to show a premalignant change of ADH (atypical ductal hyperplasia). It also involves a wider use of the vacuum assisted core biopsy as a tool for verifying nonpalpable changes identified by mammography. AIM: This paper describes our experience of 134 cases of ADH diagnosed at Mammotome(®) vacuum core needle biopsy.
MATERIAL AND METHODS: Of 4326 mammotomic biopsies performed at our institution in 2000-2006, ADH was diagnosed in 134 patients (3.1%). Patients underwent surgery to remove the suspected lesion. All histopathological blocks were again reviewed by one pathologist. Clinical, radiological and pathological data were collected for statistical evaluation.
RESULTS: Underestimation of invasive changes occurred in 12 patients (9%). The only clinicopathologic feature of statistical significance radiologically and pathologically was the presence of radial scar in the mammography.
CONCLUSIONS: More frequent diagnosis of precancerous changes in the mammotomic breast biopsy forces us to establish a clear clinical practice. The problem is the underestimation of invasive changes. The occurrence of radial scar on mammography for diagnosis of the presence of ADH increases the risk of invasive changes.

Entities:  

Keywords:  Atypical ductal hyperplasia; Breast cancer; Core biopsy

Year:  2012        PMID: 24377013      PMCID: PMC3863194          DOI: 10.1016/j.rpor.2012.03.008

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  28 in total

1.  Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy.

Authors:  R F Brem; V S Behrndt; L Sanow; O M Gatewood
Journal:  AJR Am J Roentgenol       Date:  1999-05       Impact factor: 3.959

2.  Percutaneous core needle biopsy of radial scars of the breast.

Authors:  Eva C Gombos; Robert J Poppiti
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

3.  Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.

Authors:  Jennet M Harvey; Gregory F Sterrett; Felicity A Frost
Journal:  Pathology       Date:  2002-10       Impact factor: 5.306

4.  Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions.

Authors:  J E Dahlstrom; S Sutton; S Jain
Journal:  Histopathology       Date:  1996-06       Impact factor: 5.087

5.  Predicting cancer on excision of atypical ductal hyperplasia.

Authors:  Erin Doren; Melissa Hulvat; Jonathan Norton; Prabha Rajan; Sharfi Sarker; Gerard Aranha; Katharine Yao
Journal:  Am J Surg       Date:  2008-03       Impact factor: 2.565

6.  Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?

Authors:  Roger J Jackman; Robyn L Birdwell; Debra M Ikeda
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

7.  Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy.

Authors:  L Liberman; J H Smolkin; D D Dershaw; E A Morris; A F Abramson; P P Rosen
Journal:  Radiology       Date:  1998-07       Impact factor: 11.105

8.  The role of sentinel node biopsy in ductal carcinoma in situ of the breast.

Authors:  K Polom; D Murawa; J Wasiewicz; W Nowakowski; P Murawa
Journal:  Eur J Surg Oncol       Date:  2008-08-23       Impact factor: 4.424

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  Social support for cancer-Selected problems.

Authors:  Dorota Bernad; Monika Zysnarska; Renata Adamek
Journal:  Rep Pract Oncol Radiother       Date:  2010-04-09
View more
  5 in total

1.  Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.

Authors:  Gelareh Farshid; Suzanne Edwards; James Kollias; Peter Grantley Gill
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

2.  Ultrasound-guided cable-free 13-gauge vacuum-assisted biopsy of non-mass breast lesions.

Authors:  Jiwoon Seo; Sun Mi Kim; Mijung Jang; Bo La Yun; Soo Hyun Lee; Eun-Kyu Kim; Eunyoung Kang; So Yeon Park; Woo Kyung Moon; Hye Young Choi; Bohyoung Kim
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

3.  The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer.

Authors:  Tao Sun; Hanwen Zhang; Wei Gao; Qifeng Yang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

4.  First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth Am O'Flynn; Christopher Comstock; Claudia Kurtz; Rahel Kubik; Helmut Madjar; Domenico Lepori; Gert Kampmann; Alexander Mundinger; Astrid Baege; Thomas Decker; Stefanie Hosch; Christoph Tausch; Jean-François Delaloye; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2016-08-13       Impact factor: 4.872

5.  Clinical predictors of malignancy in patients diagnosed with atypical ductal hyperplasia on vacuum-assisted core needle biopsy.

Authors:  Diana Hodorowicz-Zaniewska; Karolina Brzuszkiewicz; Joanna Szpor; Wojciech Kibil; Andrzej Matyja; Katarzyna Dyląg-Trojanowska; Piotr Richter; Antoni M Szczepanik
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-02-15       Impact factor: 1.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.